Literature DB >> 28377113

Hemorrhagic stroke secondary to Bothrops spp. venom: A case report.

Anna Beatriz Temoteo Delgado1, Caio Cesar Vaz Lacet Gondim2, Lucas Pereira Reichert3, Pedro Hugo Vieira da Silva4, Rodrigo Marmo da Costa E Souza5, Thiago Monteiro de Paiva Fernandes6, Bernardino Fernandez Calvo7.   

Abstract

The Bothrops spp. venom contain metalloproteinases that contributes to vascular and hemorrhagic effects. This case report describes a 58 years-old patient from the city of Dona Inês, Paraiba, Brazil victim of an ophidian accident by Bothrops spp. The vascular and hemorrhagic effects of venom components have triggered a hemorrhagic stroke. Brazil has about 600 deaths annually due to ophidian accidents. However, as reports have been precarious, the obtaining of epidemiological-clinical data has been affected. This case highlights the importance of prior knowledge of possible neurological and vascular complications in Bothrops spp. venom to increase the effectiveness of an adequate treatment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bothrops; Case report; Snakebite; Stroke; Venom

Mesh:

Substances:

Year:  2017        PMID: 28377113     DOI: 10.1016/j.toxicon.2017.03.015

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  2 in total

1.  Systemic alterations induced by phospholipase A2 , BmooTX-I, isolated from Bothrops moojeni snake venom.

Authors:  Kellen Cristina Torres Costa; Bruna Barbosa de Sousa; Edigar Henrique Vaz Dias; Déborah Fernanda da Cunha Pereira; Mariana Santos Matias; Wilson Júnior Oliveira; Antônio Vicente Mundim; Carla Cristine Neves Mamede; Luíz Fernando Moreira Izidoro; Júnia de Oliveira Costa; Fábio de Oliveira
Journal:  Int J Exp Pathol       Date:  2018-11-20       Impact factor: 1.925

2.  Cerebrovascular Accident and Snake Envenomation: A Scoping Study.

Authors:  Mohammed Al-Sadawi; Maliheh Mohamadpour; Angelina Zhyvotovska; Tahir Ahmad; Joshua Schechter; Yasmin Soliman; Samy I McFarlane
Journal:  Int J Clin Res Trials       Date:  2019-04-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.